文献速递脑血管病外科

微小血管:67例直径小于2.0毫米远端血管动脉瘤的血流导向治疗

Tiny Pipes: 67 Cases of Flow Diversion for Aneurysms in Distal Vessels Measuring Less Than 2.0 mm.
PubMed 文献 · World Neurosurg · 2019-03-13

回顾性分析57例患者67个远端血管动脉瘤,使用2.5毫米直径Pipeline血流导向装置治疗,血管直径小于2.0毫米。主要安全事件包括3例(4.5%)重大卒中导致永久性神经功能缺损,其中1例(1.5%)死亡。6个月、12个月和末次随访完全闭塞率分别为88%、86%和89%。作者认为血流导向治疗对于起源于直径小于2.0毫米血管的动脉瘤是安全有效的。

要点

  • 67个动脉瘤中66个(99%)手术成功,64个(96%)使用单一装置。
  • 3例(4.5%)重大卒中导致永久性神经功能缺损,1例(1.5%)死亡。
  • 6个月、12个月和末次随访完全闭塞率分别为88%、86%和89%。

核心结论

  • 血流导向治疗对于起源于直径小于2.0毫米血管的动脉瘤是安全有效的。
  • 在这些病例中,需要高度警惕预防和管理急性支架和血管血栓形成。

研究设计与样本

  • 前瞻性收集的机构审查委员会批准的脑动脉瘤数据库回顾性分析。
  • 57例患者,67个动脉瘤,67次手术,使用2.5毫米直径Pipeline血流导向装置。
  • 平均年龄56岁,60%为女性。

主要发现

  • 动脉瘤位置:51个(76%)大脑前动脉,14个(21%)大脑中动脉,2个(3%)大脑后动脉。
  • 动脉瘤大小4.1±3.0毫米(范围1-20毫米)。
  • 安全结局:3例(4.5%)重大卒中导致永久性神经功能缺损(改良Rankin量表评分6、4、4),包括1例(1.5%)死亡。
  • 急性支架血栓形成在术中或每次卒中后24小时内观察到。
  • 2例(3.0%)小体积(小于10立方厘米,40立方厘米)依赖性颅内出血,无永久性神经功能缺损。

关键数值与推荐

  • 使用2.5毫米直径Pipeline血流导向装置治疗直径小于2.0毫米血管的动脉瘤。
  • 完全闭塞定义未在原文中明确报告。

临床怎么用

  • 作者认为血流导向治疗对于起源于直径小于2.0毫米血管的动脉瘤是安全有效的。
  • 作者认为在这些病例中需要高度警惕预防和管理急性支架和血管血栓形成。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Flow diversion is increasingly used for off-label treatments of distal circulation aneurysms. Reports of use in sub-2.0-mm vessels are scant. METHODS: A prospectively collected, institutional review board-approved cerebral aneurysm database was reviewed to identify patients who underwent flow diversion with a 2.5-mm diameter Pipeline embolization device. RESULTS: Sixty-seven aneurysms were treated in 67 procedures (66 [99%] successful, 64 [96%] single device, 2 [3%] with 2 devices) in 57 patients. Average age was 56 years and 60% were female. Aneurysm location was 51 (76%) anterior cerebral artery, 14 (21%) middle cerebral artery, and 2 (3%) posterior cerebral artery. Aneurysm size was 4.1 ± 3.0 mm (1-20 mm). Safety outcomes included 3 major strokes (4.5%) resulting in permanent neurologic deficit (modified Rankin Scale score 6,4,4), including 1 mortality (1.5%). Acute stent thrombosis was observed intraprocedurally or within 24 hours of each stroke. There were 2 small-volume (<10 cm3, 40 cm3) dependent intracerebral hemorrhage (3.0%) that resolved without permanent neurologic deficit. For effectiveness, 71% of patients underwent follow-up angiography. Complete occlusion was achieved by 88% at 6 months, 86% at 12 months, and 89% at last follow-up. A slight vessel diameter reduction was apparent on average 6.9 months after the procedure, which was statistically significant at the proximal (P = 0.001) but not distal (P = 0.317) device end. Preoperative average parent vessel diameter was 1.9 mm proximally (range, 1.1-2.6 mm) and 1.7 mm distally (range, 1.0-2.3 mm) of the Pipeline embolization device. Follow-up average vessel diameter was 1.7 mm proximally (range, 0.7-2.4 mm) and 1.6 mm distally (range, 0.6-2.1 mm). Flow delay associated with vessel diameter reduction occurred once. There were no cases of asymptomatic vessel occlusion. CONCLUSIONS: Flow diversion can be safe and effective for aneurysms originating from vessels <2.0 mm in diameter. Heightened vigilance for the prevention and management of acute stent and vessel thrombosis is warranted in these cases.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Bender MT, Zarrin DA, Campos JK, et al. Tiny Pipes: 67 Cases of Flow Diversion for Aneurysms in Distal Vessels Measuring Less Than 2.0 mm. World Neurosurg. 2019. PMID: 30878751. doi:10.1016/j.wneu.2019.02.204

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。